Výsledky vyhledávání

Effectiveness of patient education for patients with osteoporosis: a systematic review

Autor: S Andersen, B M T Schønwandt, M F Hitz, Teresa Holmberg, M Rubæk

Publikováno v: Osteoporosis International. 33:959-977

In this systematic review, the effects of osteoporosis patient education were examined. All studies found an effect on physical function, but for the other themes, the results were inconclusive. The findings indicate a need for further research in th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aa9bb0ba37f6523c44b301754f621d11
https://doi.org/10.1007/s00198-021-06226-5

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Role of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma – Data from the Prospective, Multicenter Phase III HD16 Trial

Autor: L. van Heek, C. Stuka, H. Kaul, J. Mettler, F. Hitz, C. Baues, M. Fuchs, P. Borchmann, A. Engert, M. Dietlein, C.A. Voltin, C. Kobe

Publikováno v: 60. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::413afcc714ea28cf81c371e88b746f7d
https://doi.org/10.1055/s-0042-1745979

Zobrazit plný text záznamu

Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study

Autor: S E, Bønløkke, M S, Rand, B, Haddock, S, Arup, C D, Smith, J E B, Jensen, P, Schwarz, P, Hovind, P S, Oturai, L T, Jensen, S, Møller, P, Eiken, K H, Rubin, M F, Hitz, B, Abrahamsen, N R, Jørgensen

Publikováno v: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 33(10)

Anti-resorptive osteoporosis treatment might be more effective in patients with high bone turnover. In this registry study including clinical data, high pre-treatment bone turnover measured with biochemical markers was correlated with higher bone min

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f16e68fe2c0db0f9148406cdca09d524
https://pubmed.ncbi.nlm.nih.gov/35729342

Zobrazit plný text záznamu

Effectiveness of patient education for patients with osteoporosis: a systematic review

Autor: M, Rubæk, M F, Hitz, T, Holmberg, B M T, Schønwandt, S, Andersen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8f1b400ae9f7e63e946166dccef000ac
https://pubmed.ncbi.nlm.nih.gov/34773131

Zobrazit plný text záznamu

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)

Autor: F. Hitz, M. Kraus, T. Pabst, D. Hess, L. Besse, T. Silzle, U. Novak, K. Seipel, S. Rondeau, S. Stüdeli, S. Berardi Vilei, P. Samaras, U. Mey, C. Driessen, for the Swiss Group for Clinical Cancer Research SAKK

Publikováno v: Blood Cancer Journal, Vol 9, Iss 9, Pp 1-8 (2019)
Hitz, F; Kraus, M; Pabst, Thomas; Hess, D; Besse, L; Silzle, T; Novak, Urban; Seipel, Katja; Rondeau, S; Stüdeli, S; Vilei, S Berardi; Samaras, P; Mey, U; Driessen, C (2019). Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood cancer journal, 9(9), p. 70. Springer Nature 10.1038/s41408-019-0228-2
Blood Cancer Journal

The antiretroviral agent nelfinavir has antimyeloma activity and can overcome resistance to bortezomib. Our phase I/II trial investigated whether adding nelfinavir to lenalidomide–dexamethasone can overcome lenalidomide resistance in lenalidomide-r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09dcc16e1fd8629234b44651d327686
http://link.springer.com/article/10.1038/s41408-019-0228-2

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání